Cargando...

Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer

For many years, preclinical and clinical studies have attempted to harness the power of the immune system and focus it on malignant cells in an attempt to improve clinical outcomes for patients with cancer. The current paper describes the landmark phase III trial that led to the first U.S. Food and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Madan, Ravi A., Gulley, James L.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3474245/
https://ncbi.nlm.nih.gov/pubmed/21174555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.10.77
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!